Results 231 to 240 of about 582,867 (329)

Analysis of Rectal Neoplasms Operated After Neoadjuvant Therapy in A Period of 10 Years

open access: green, 2020
Humberto Fenner Lyra   +6 more
openalex   +2 more sources

Polygenic risk score and prostate specific antigen predict death from prostate cancer in men with intermediate aggressive cancer

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Using 21 SNPs, two novel PRS were constructed and used to develop two new machine‐learning classifiers, one for the detection of prostate cancer and the other for the prediction of its aggressiveness and subsequent mortality. The classifier for disease detection is built using the PRS as the sole feature, whereas the one for disease ...
Leandro Rodrigues Santiago   +3 more
wiley   +1 more source

Effect of endoscopic treatment for lesions in radiotherapy field after radiotherapy for rectal cancer. [PDF]

open access: yesBMC Gastroenterol
Zha B   +7 more
europepmc   +1 more source

Pan‐cancer analysis reveals molecular signatures for predicting matrix stiffness in solid tumors

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Tumor matrix stiffness plays a critical role in cancer progression, metastasis, and therapy resistance. Here, the authors leveraged tumor RNA‐seq data to identify molecular signatures of mechanical properties across various cancer types and build a computational model for predicting tumor matrix stiffness.
Gongyu Tang   +6 more
wiley   +1 more source

Transvaginal approach for resection of a low rectal leiomyoma: A case report. [PDF]

open access: yesInt J Surg Case Rep
Doan TT   +4 more
europepmc   +1 more source

Enfortumab vedotin plus pembrolizumab in treatment‐naïve metastatic urothelial carcinoma patients: An Austrian real‐world analysis

open access: yesInternational Journal of Cancer, EarlyView.
What's New? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke   +30 more
wiley   +1 more source

Is there a role for total neoadjuvant treatment in early-stage rectal cancer? [PDF]

open access: yesLangenbecks Arch Surg
Erozkan K   +7 more
europepmc   +1 more source

Risk of cancer among individuals with a history of bacterial sexually transmitted infections: A population‐based study in Alberta, Canada

open access: yesInternational Journal of Cancer, EarlyView.
What's New? While previous studies have identified the carcinogenicity of viral agents such as HIV, the role of bacterial sexually transmitted infections in carcinogenesis remains understudied despite them similarly causing chronic inflammation.
Hina M. Qureshi   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy